| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 06/23/2005 | US20050137249 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1; nontoxic |
| 06/23/2005 | US20050137243 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
| 06/23/2005 | US20050137242 Betamimetics having a long-lasting activity, processes for preparing them, and their use as medicaments |
| 06/23/2005 | US20050137234 Histone deacetylase inhibitors |
| 06/23/2005 | US20050137232 Histone deacetylase inhibitors |
| 06/23/2005 | US20050137228 Benzyl sulfonamide derivatives |
| 06/23/2005 | US20050137216 Heterocyclic sodium/proton exchange inhibitors and method |
| 06/23/2005 | US20050137215 Antiarthritic and antiinflammatory agents; analgesics; the proline derivatives do not displace gabapentin from alpha-2-delta receptors |
| 06/23/2005 | US20050137212 Hppars activators |
| 06/23/2005 | US20050137202 Heterocyclic compounds as antiinflammatory agents and cyclooxygenase inhibitors |
| 06/23/2005 | US20050137201 Compositions useful as inhibitors of protein kinases |
| 06/23/2005 | US20050137196 Medical devices employing triazine compounds and compositions thereof |
| 06/23/2005 | US20050137195 Thermodynamically stable |
| 06/23/2005 | US20050137193 Antagonists of the chemokine receptor 9 (CCR9); inhibit TECK ligand; antiinflammatory agents and immunoregulators; inflammatory bowel disease; (2-phenylsulfonamidophenyl)-pyridinyl-methanones; N-[4-chloro-2(pyridine4-carbonyl)-phenyl]4-morpholin-4-yl-benzenesulfonamide |
| 06/23/2005 | US20050137190 Compositions useful as inhibitors of voltage-gated sodium channels |
| 06/23/2005 | US20050137179 Potent antagonists of chemokine receptors and controls in drug screening assays; antiallergens, antiinflammatory, antifibrotic, antiarthritic, and anticarcinogenic agents; inflammatory bowel disease |
| 06/23/2005 | US20050137168 inhibit the formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor; for treatment and/or prevention of arterial and venous thrombosis, deep vein thrombosis, pulmonary embolism, unstable angina pectoris, cardiac infarction, stroke |
| 06/23/2005 | CA2549401A1 Heterocyclic anti-migraine agents |
| 06/23/2005 | CA2549355A1 The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same |
| 06/23/2005 | CA2549273A1 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/23/2005 | CA2549272A1 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/23/2005 | CA2548742A1 Dpp-iv inhibitors |
| 06/23/2005 | CA2548426A1 Substituted piperazines |
| 06/23/2005 | CA2548172A1 Quinoxalines useful as inhibitors of protein kinases |
| 06/23/2005 | CA2547573A1 N-alkyl pyrroles as hmg-coa reductase inhibitors |
| 06/23/2005 | CA2547410A1 1,2,3-triazole amide derivatives as inhibitors of cytokie production |
| 06/23/2005 | CA2547391A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 06/23/2005 | CA2546895A1 Oxazole derivatives of tetracyclines |
| 06/22/2005 | EP1543017A2 Bifunctional heterocyclic compounds and methods of making and using same |
| 06/22/2005 | EP1542997A2 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents |
| 06/22/2005 | EP1542995A1 Novel isothiazole and isoxazole compounds as transforming growth factor (tgf) inhibitors |
| 06/22/2005 | EP1542994A1 Novel triazole and oxazole compounds as transforming growth factor (tgf) inhibitor |
| 06/22/2005 | EP1542990A1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors |
| 06/22/2005 | EP1542972A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 06/22/2005 | EP1542696A1 Oxazolidinone derivatives as antimicrobials |
| 06/22/2005 | EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 06/22/2005 | EP1542685A1 Triazole derivatives as transforming growth factor (tgf) inhibitors |
| 06/22/2005 | EP1542684A2 Novel pyrazole compounds as transforming growth factor (tgf) inhibitors |
| 06/22/2005 | EP1345933B1 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 06/22/2005 | EP1282619B1 Processes for the preparation of thiazolidinedione derivatives and intermediates |
| 06/22/2005 | EP1268466B1 Decahydro-isoquinolines |
| 06/22/2005 | EP1154774B1 Quinazoline derivatives as angiogenesis inhibitors |
| 06/22/2005 | CN1630655A Dual action antibiotics |
| 06/22/2005 | CN1630651A Novel gamma secretase inhibitors |
| 06/22/2005 | CN1630650A Nitrogenous heterocyclic compound and medicine thereof |
| 06/22/2005 | CN1630642A Benzenesulfonamide derivatives |
| 06/22/2005 | CN1630640A Novel enantiomer of tetra hydrogen isoquinoline derivative and officinal salt, preparation and pharmaceutical composition thereof |
| 06/22/2005 | CN1630637A Novel arylheteroalkylamine derivatives |
| 06/22/2005 | CN1630633A N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 06/22/2005 | CN1630632A Aromatic amino acid derivates and medicinal compositions |
| 06/22/2005 | CN1207289C Metalloproteinase inhibitors, pharmaceutical compositions containing the same and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 06/22/2005 | CN1207288C Retroviral protease inhibiting compounds |
| 06/22/2005 | CN1207056C Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors |
| 06/21/2005 | US6909005 One post synthesis of 2-oxazolidinone derivatives |
| 06/21/2005 | US6908940 Imidazole compounds and their use as adenosine deaminase inhibitors |
| 06/21/2005 | US6908938 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 06/21/2005 | US6908937 Heterocyclic fluoroalkenyl thioethers (II) |
| 06/21/2005 | US6908931 1-(2,2-diphenyl-ethyl)-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline- 2-carbaldehyde; for treating sleep disorders |
| 06/21/2005 | US6908923 Compositions and methods for treating heart failure |
| 06/21/2005 | US6908922 Linear cyclic ureas |
| 06/21/2005 | US6908920 Pyrimidine derivatives |
| 06/21/2005 | US6908919 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 06/21/2005 | US6908908 Biologically active 4H-benzo [1,4] oxazin-3-ones |
| 06/16/2005 | WO2005054430A2 Hepatitis c virus inhibitors |
| 06/16/2005 | WO2005054234A2 Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy |
| 06/16/2005 | WO2005054213A1 Isoxazole derivative having agonistic activity against peroxisome proliferator-activated receptor |
| 06/16/2005 | WO2005054199A1 Tubulin inhibitors |
| 06/16/2005 | WO2005054179A2 Hydroxamic acid esters and pharmaceutical use thereof |
| 06/16/2005 | WO2005053663A2 Norepinephrine reuptake inhibitors useful for treatment of cognitive failure |
| 06/16/2005 | WO2005053631A1 Microcapsules with uv filter activity and process for producing them |
| 06/16/2005 | WO2005053628A1 Use of osteopontin in dental formulations |
| 06/16/2005 | WO2005040116A3 Indolinone derivatives and their use in treating disease-states such as cancer |
| 06/16/2005 | WO2005032550A3 Peptide deformylase inhibitors |
| 06/16/2005 | WO2005025293A3 Fused ring heterocycles as potassium channel modulators |
| 06/16/2005 | WO2005002552A3 Benzimidazole derivatives and their use as protein kinases inhibitors |
| 06/16/2005 | WO2004096286A3 Antiviral phosphonate analogs |
| 06/16/2005 | US20050131043 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles |
| 06/16/2005 | US20050131038 Process for the preparation of valsartan and intermediates thereof |
| 06/16/2005 | US20050131014 Anticholesterol agents; antidiabetic agents; cardiovascular disorders ; antiarthritic agents |
| 06/16/2005 | US20050131002 Anticholesterol agents; antilipemic agents; cardiovascular disorders; antiischemic agents; anticancer agents |
| 06/16/2005 | US20050131001 Anticholesterol agents; antilipemic agents; antiischemic agents; cardiovascular disorders |
| 06/16/2005 | US20050131000 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity |
| 06/16/2005 | US20050130981 Compounds |
| 06/16/2005 | US20050130976 Bicyclic inhibitors of MEK and methods of use thereof |
| 06/16/2005 | US20050130968 Fungicidal 4-(2-aminopyridin-4-yl)-N-phenyl-1,3,5-triazin-2-amine derivatives |
| 06/16/2005 | US20050130967 3-Substituted-4-pyrimidone derivatives |
| 06/16/2005 | US20050130964 e.g 8-oxa-1-thia-benzo[e]naphtho[3,2-h]azulene-2-carboxylic acid ethyl ester; rheumatoid arthritis |
| 06/16/2005 | US20050130963 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity |
| 06/16/2005 | US20050130962 Seratonin receptor antagonist; central nervous system disorders; halo phenyl substituents |
| 06/16/2005 | US20050130959 Selective in presence of at least one other cathepsin isozyme; such as (3-cyclopentyl-{[5-(3-fluoro-phenyl)-furan-2-carbonyl]-amino}-propionylamino)-4-oxo-butyric acid |
| 06/16/2005 | US20050130943 Bicyclic inhibitors of MEK and methods of use thereof |
| 06/16/2005 | US20050130910 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents; drug screening |
| 06/16/2005 | CA2857067A1 Tubulin inhibitors |
| 06/16/2005 | CA2549242A1 Hydroxamic acid esters and pharmaceutical use thereof |
| 06/16/2005 | CA2547066A1 Advanced indolinone based protein kinase inhibitors |
| 06/16/2005 | CA2545425A1 Azole-based kinase inhibitors |
| 06/16/2005 | CA2545422A1 Tubulin inhibitors |
| 06/15/2005 | EP1541558A1 Heterocyclic compound having hiv integrase inhibitory activity |
| 06/15/2005 | EP1541143A1 Dpp-iv inhibitors |
| 06/15/2005 | EP1539766A1 Calcitonin gene related peptide receptor antagonists |